There are no products in your shopping cart.
Jennifer's Story Links
In the past few years, the FDA has been criticized for late responses to reports of side effects for some antidepressants, the smoking cessation drug Chantrix and the painkiller Vioxx.
Yet Monday's announcement from the FDA proposing a new "black box" suicide risk warning label be added to 11 epilepsy drugs, some of which are also used for pain management, has some suggesting the FDA is overreacting. Today the FDA will hold an advisory panel to hear from epilepsy experts on the proposed black box label.
- Login or register to post comments
- report spam









Recent Comments
1 week 1 hour ago
1 week 1 day ago
4 weeks 2 days ago
8 weeks 1 day ago
9 weeks 2 hours ago
12 weeks 5 days ago
13 weeks 6 days ago
15 weeks 6 days ago
17 weeks 1 day ago
18 weeks 3 hours ago